Shi, Guang-Li <br/><br/>
Reduction of Serum Cytokeratin-3A9 is Associated with Chemotherapeutic Response in Patients with Non-Small Cell Lung Cancer.  [electronic resource] 

 -  Clinical laboratory  2015 
 - 497-504 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1433-6510 
<br/><br/><label>Standard No.: </label>10.7754/clin.lab.2014.140819  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers--blood<br/>Carcinoma, Non-Small-Cell Lung--blood<br/>Case-Control Studies<br/>Cisplatin--therapeutic use<br/>Female<br/>Humans<br/>Keratins--blood<br/>Lung Neoplasms--blood<br/>Male<br/>Middle Aged